Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonsense suppression therapies in human genetic diseases
Patrícia Martins-Dias, Luı́sa Romão
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 10, pp. 4677-4701
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Targeted pseudouridylation: An approach for suppressing nonsense mutations in disease genes
Hironori Adachi, Yi Pan, Xueyang He, et al.
Molecular Cell (2023) Vol. 83, Iss. 4, pp. 637-651.e9
Open Access | Times Cited: 44
Nonsense-Mediated mRNA Decay, a Finely Regulated Mechanism
Fabrice Lejeune
Biomedicines (2022) Vol. 10, Iss. 1, pp. 141-141
Open Access | Times Cited: 43
Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons
Markus T. Sainio, Tiina Rasila, Svetlana M. Molchanova, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 41
Nonsense-mediated mRNA decay, a simplified view of a complex mechanism
Julie Carrard, Fabrice Lejeune
BMB Reports (2023) Vol. 56, Iss. 12, pp. 625-632
Open Access | Times Cited: 17
Mistranslating the genetic code with leucine in yeast and mammalian cells
Josephine Davey-Young, Farah Hasan, Rasangi Tennakoon, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-23
Open Access | Times Cited: 7
P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds
Gazmend Temaj, Silvia Chichiarelli, Pelin Telkoparan‐Akillilar, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116332-116332
Closed Access | Times Cited: 5
PDZD8 Disruption Causes Cognitive Impairment in Humans, Mice, and Fruit Flies
Ahmed H. Al-Amri, Paul Armstrong, Mascia Amici, et al.
Biological Psychiatry (2022) Vol. 92, Iss. 4, pp. 323-334
Open Access | Times Cited: 21
Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis
Catherine Leroy, Sacha Spelier, Nadège Charlène Essonghé, et al.
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 970-985
Open Access | Times Cited: 13
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development
Shan Li, Juan Li, Wenjing Shi, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 988-988
Open Access | Times Cited: 13
Molecular mechanisms of eukaryotic translation fidelity and their associations with diseases
Dejiu Zhang, Lei Zhu, Fei Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124680-124680
Closed Access | Times Cited: 12
Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders
Beverly L. Davidson, Guangping Gao, Elizabeth Berry‐Kravis, et al.
Molecular Therapy (2022) Vol. 30, Iss. 7, pp. 2416-2428
Open Access | Times Cited: 18
Inhibition of nonsense-mediated mRNA decay may improve stop codon read-through therapy for Duchenne muscular dystrophy
Adi Amar-Schwartz, Yuval Cohen, Antony Elhaj, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 15, pp. 2455-2463
Closed Access | Times Cited: 10
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies
Lingling Hou, Xiaoli Chen, Haixiao Xie, et al.
Blood Coagulation & Fibrinolysis (2025) Vol. 36, Iss. 2, pp. 51-57
Closed Access
TLR5’s Role in Obesity-related Hypertension: Updated Evidence and Prospects
Ou Wu, Jin Nan Gao, Xingyu Zhang, et al.
Angiology (2025)
Closed Access
Identification and functional validation of a novel FBN1 variant in a Marfan syndrome family using a zebrafish model
Shitong Huang, Jiansong Chen, Qiuyu Wang, et al.
BMC Genomics (2025) Vol. 26, Iss. 1
Open Access
Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo
Huiying Li, Yuhao Qiu, Bowen Song, et al.
Nature Biotechnology (2025)
Closed Access
Therapeutic Potential of Translational Readthrough at Disease‐Associated Premature Termination Codons From Tumor Suppressor Genes
Leire Torices, Caroline E. Nunes‐Xavier, Rafael Pulido
IUBMB Life (2025) Vol. 77, Iss. 5
Open Access
MyoAAV-delivered sup-tRNA increases full-length dystrophin expression
X. Ai, Yue Chang, Ruo Wu, et al.
Genes & Diseases (2025), pp. 101666-101666
Open Access
Emerging Personalized Opportunities for Enhancing Translational Readthrough in Rare Genetic Diseases and Beyond
Roland N. Wagner, Michael Wießner, Andreas Friedrich, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6101-6101
Open Access | Times Cited: 8
Restoring susceptibility to aminoglycosides: identifying small molecule inhibitors of enzymatic inactivation
Angel J. Magaña, Jan Sklenicka, Clemencia Pinilla, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 9, pp. 1591-1602
Closed Access | Times Cited: 8
Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches
Pedro Morais, R. Zhang, Yi‐Tao Yu
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1284-1284
Open Access | Times Cited: 3
mRNA-specific readthrough of nonsense codons by antisense oligonucleotides (R-ASOs)
Denis Susorov, Dimas Echeverria, Anastasia Khvorova, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 15, pp. 8687-8701
Open Access | Times Cited: 3
UPF1: From mRNA Surveillance to Protein Quality Control
Hyun Jung Hwang, Yeonkyoung Park, Yoon Ki Kim
Biomedicines (2021) Vol. 9, Iss. 8, pp. 995-995
Open Access | Times Cited: 20
Stop Codon Context-Specific Induction of Translational Readthrough
Mirco Schilff, Yelena Sargsyan, Julia Hofhuis, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 18
The potential value of amlexanox in the treatment of cancer: Molecular targets and therapeutic perspectives
Christian Bailly
Biochemical Pharmacology (2021) Vol. 197, pp. 114895-114895
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top